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    Different types of tissues have a characteristic cell morphology. Each cell has typical 
molecules on its surface, which may be either of physiological or pathological type. The 
presence of these surface structures can be interesting for possible modulation of specific 
cell populations from neighboring cells. Utilization of this property is then essential 
particularly in a case of tumor cells. Targeting on tumor specific cell structures involves the 
use of receptor specific peptides or monoclonal antibodies. The discovery of the preparation 
of monoclonal antibodies has opened a new chapter in the treatment and diagnosis not only 
tumor diseases. The advantage of monoclonal antibodies is their specificity and also high 
affinity to the type of the target cell structures. 
     This study is focused on the summary of monoclonal antibodies which are currently being 
applied on the treatment or diagnosis of a particular cancer. Furthermore, this work also 
includes antibodies which are under development for intended medical applications with 
promising results of clinical studies. The work is moreover concentrated on particular those 
antibodies which are labeled radioactively. The presence of radioactive emitters brings many 
positive in terms of diagnostic sensitivity or effective therapeutic tool in the form of 
radiolabeled antibodies. 
     However, the selection of promising radiolabeled antibodies as radiopharmaceuticals is 
very small. Radiation in itself brings many complications in terms of issues in handling of 
radioactive material, a radioactive burden for patients and nursing staff, as well as 
complications with radioactive labeling of the monoclonal antibodies. Nevertheless, the 
advantages of radiolabeled antibodies in diagnosis due to the high sensitivity outweigh the 
risks mentioned above. Radiotherapy may seem a little complicated, but the specificity of 
antibodies and the appropriate type of radionuclide may mean for the treated patients the 
improvement of their health. 
 
Keywords: monoclonal antibody, radionuclide, radiopharmaceutical, immunoglobulin, 
immunotherapy, conjugated antibody 
                                               
